Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Dermata Therapeutics Inc increased its cash reserves by 19.18%, or 1.20m. Cash Flow from Financing totalled 7.61m or -- of revenues. In addition the company used 6.41m for operations while cash used for investing totalled .
Cash flow per share | -3.03 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 4.79 |
---|---|
Tangible book value per share | 4.79 |
More ▼
Balance sheet in USDView more
Current ratio | 2.73 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼